The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder
about
The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortexNeuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapsesLow dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?Targeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive DisordersEarly Postnatal Manganese Exposure Causes Lasting Impairment of Selective and Focused Attention and Arousal Regulation in Adult Rats.Differential cognitive actions of norepinephrine a2 and a1 receptor signaling in the prefrontal cortexA translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessationDevelopment and validation of a simple, sensitive and accurate LC-MS/MS method for the determination of guanfacine, a selective α2A -adrenergicreceptor agonist, in plasma and its application to a pharmacokinetic study.Alpha 2A adrenergic receptor agonist, guanfacine, attenuates cocaine-related impairments of inhibitory response control and working memory in animal models.Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic α₁ - and α₂-receptors.Effects of α-2A adrenergic receptor agonist on time and risk preference in primatesSystematic review: pharmacological treatment of tic disorders--efficacy of antipsychotic and alpha-2 adrenergic agonist agents.Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings.Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents.Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective.Alternative pharmacological strategies for adult ADHD treatment: a systematic review.Evaluation of guanfacine as a potential medication for alcohol use disorder in long-term drinking rats: behavioral and electrophysiological findings.The effect of cognitive challenge on delay discounting.Methylphenidate alleviates manganese-induced impulsivity but not distractibility.Absolute Theta Power in the Frontal Cortex During a Visuomotor Task: The Effect of Bromazepam on Attention.The Alpha-2A Adrenergic Receptor Gene -1291C/G Single Nucleotide Polymorphism is Associated with the Efficacy of Methylphenidate in Treating Taiwanese Children and Adolescents with Attention-Deficit Hyperactivity Disorder.Targeting Stress Neuroadaptations for Addiction Treatment: A Commentary on Kaye et al. (2017).Palmitoylation as a Functional Regulator of Neurotransmitter Receptors.
P2860
Q22252343-DB445998-0C0D-419D-91C9-78CE2D3A49B3Q24619549-E9287942-7DDE-4BFC-B8F5-E267D931ED2BQ27026214-B4FB051D-30E6-4E55-A63F-2ADDAD87B2F9Q28076907-6565615A-0449-4A85-875D-96A0C9F0AD62Q30151937-DF88F8E7-B54F-407E-AC60-9E21FEA02DC6Q30354144-9EAA8A78-E1A8-4786-B6FA-CCD1A8B43D37Q34454236-3AA0305F-C273-4674-AB75-B5B51869B0EFQ34801634-9D38A24B-1591-4D64-86A9-41DC29AF421BQ35120282-D38A254B-8AB2-4B6D-862A-B6955415DEE6Q35600790-91FBB307-EB10-422C-8162-33F6044462DCQ35721180-F71BDE35-B1F9-4C5F-A9A7-95450DA4FD2BQ36906661-1AB25D0C-F2DF-43E5-9B57-4410B603A885Q36959712-62BAD843-D896-491F-AED3-883F1E91DF3EQ38225962-17AAAB72-54C5-4712-8F2E-E9D8EA370CDBQ38635337-ED71D86A-9BE4-4D5B-88A8-FC436A01CAF1Q38676199-1428AE49-A25B-4AD1-A11F-19026E9C4A19Q43195621-1409FB16-D82B-481F-8C7D-7C0494977DD9Q46054231-D318216B-0601-45BB-9C58-3259D2DE1492Q46786498-2E8E97B8-E041-4C71-820C-3A0AF7E470A5Q48456875-A19F932F-C4A7-450E-827F-66BF1BDCEA47Q51746911-56564DAF-AE20-4A14-8340-C3767FA468BFQ52312980-8AE81CFA-7109-47D6-A15B-905BBB40ED09Q55256658-42E995B7-D2E9-4FC8-B394-D456E9F726A3
P2860
The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The use of α-2A adrenergic ago ...... deficit/hyperactivity disorder
@ast
The use of α-2A adrenergic ago ...... deficit/hyperactivity disorder
@en
The use of α-2A adrenergic ago ...... deficit/hyperactivity disorder
@nl
type
label
The use of α-2A adrenergic ago ...... deficit/hyperactivity disorder
@ast
The use of α-2A adrenergic ago ...... deficit/hyperactivity disorder
@en
The use of α-2A adrenergic ago ...... deficit/hyperactivity disorder
@nl
prefLabel
The use of α-2A adrenergic ago ...... deficit/hyperactivity disorder
@ast
The use of α-2A adrenergic ago ...... deficit/hyperactivity disorder
@en
The use of α-2A adrenergic ago ...... deficit/hyperactivity disorder
@nl
P2860
P3181
P356
P1476
The use of α-2A adrenergic ago ...... deficit/hyperactivity disorder
@en
P2093
Amy F T Arnsten
P2860
P304
P3181
P356
10.1586/ERN.10.133
P407
P577
2010-10-01T00:00:00Z